Coughlin Elizabeth Reid sold $754K of AXON
Coughlin Elizabeth Reid (Chief Human Officer) sold 1,554 shares of AXON ENTERPRISE, INC. (AXON) at $485.00 ($0.75M total) on 2026-06-04.
How this was made
The 30-second read
Why it matters
It documents an officer’s open-market sale; it does not provide new operational, financial, or legal information about Axon.
Market read
Traders may note the insider sale, but there is no new company catalyst to drive a sustained repricing.
What to watch
Insider sales can be driven by diversification, tax, or personal liquidity needs; without additional filings (buys, options exercises, or material events), signal quality is low.
Background
The article is a SEC Form 4 insider transaction disclosure for Axon Enterprise, Inc.
Ticker impact
Axon chief human officer Elizabeth Reid filed an open-market sale of 1,554 shares at $485/share on 2026-06-04 (Form 4).
Low near-term impact; any reaction is likely muted and short-lived.
This is a Form 4 insider transaction with no 10b5-1 plan and no accompanying fundamental disclosure (no guidance, contract, or enforcement action).
Market effects
Minimal; insider sale does not change sector fundamentals or regulatory outlook.
None indicated.
None indicated.
Counterpoint
The absence of a 10b5-1 plan could be interpreted as discretionary selling, but the disclosed size is still small relative to typical institutional flows.
Key entities
- issuerAXON ENTERPRISE, INC.
Company whose insider transaction was reported on SEC Form 4.
- insiderCoughlin Elizabeth Reid
Chief Human Officer who sold 1,554 shares at $485/share.
